126 related articles for article (PubMed ID: 35435367)
21. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
22. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
23. Expression levels of insulin-like growth factor-1 and multidrug resistance-associated protein-1 indicate poor prognosis in patients with gastric cancer.
Ge J; Chen Z; Wu S; Chen J; Li X; Li J; Yin J; Chen Z
Digestion; 2009; 80(3):148-58. PubMed ID: 19713703
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of Notch1 and PTEN in gastric cancer].
Li DW; Wu Q; Peng ZH; Yang ZR; Wang Y
Ai Zheng; 2007 Nov; 26(11):1183-7. PubMed ID: 17991315
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of Notch1, Jagged1, NF-κB and MMP-9 in colorectal cancer patients and the relationship to clinicopathological parameters.
Zheng CG; Chen R; Xie JB; Liu CB; Jin Z; Jin C
Cancer Biomark; 2015; 15(6):889-97. PubMed ID: 26406415
[TBL] [Abstract][Full Text] [Related]
26. Notch1 activation is a poor prognostic factor in patients with gastric cancer.
Zhang H; Wang X; Xu J; Sun Y
Br J Cancer; 2014 Apr; 110(9):2283-90. PubMed ID: 24642622
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of association of OCT4 with LEF1 expression in esophageal squamous cell carcinoma and their impact on epithelial-mesenchymal transition, invasion, and migration.
Zhao Y; Li C; Huang L; Niu S; Lu Q; Gong D; Huang S; Yuan Y; Chen H
Cancer Med; 2018 Aug; 7(8):3977-3987. PubMed ID: 29974668
[TBL] [Abstract][Full Text] [Related]
28. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Significances of NEDD-9 and FOXL-1 Expression in Intestinal Type Gastric Carcinoma: an Immunohistochemical Study.
Elaidy NF; Harb OA; Mohamed AM; Hemeda R; Taha HF; Samir A; Elsayed AM; Osman G; Hendawy EIE
J Gastrointest Cancer; 2021 Jun; 52(2):728-737. PubMed ID: 32794109
[TBL] [Abstract][Full Text] [Related]
30. TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma.
Zhang T; Liang L; Liu X; Wu JN; Chen J; Su K; Zheng Q; Huang H; Liao GQ
J Oral Pathol Med; 2016 Aug; 45(7):486-93. PubMed ID: 26764364
[TBL] [Abstract][Full Text] [Related]
31. TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
[TBL] [Abstract][Full Text] [Related]
32. The Prognostic and Clinicopathologic Characteristics of OCT4 and Lung Cancer: A Meta-Analysis.
Li H; Wang L; Shi S; Xu Y; Dai X; Li H; Wang J; Zhang Q; Wang Y; Sun S; Li Y
Curr Mol Med; 2019; 19(1):54-75. PubMed ID: 30854966
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of Oct4, CD44 and c-Myc in radio-chemo-resistant oral cancer patients and their tumourigenic potential in immunodeficient mice.
Sawant S; Gokulan R; Dongre H; Vaidya M; Chaukar D; Prabhash K; Ingle A; Joshi S; Dange P; Joshi S; Singh AK; Makani V; Sharma S; Jeyaram A; Kane S; D'Cruz A
Clin Oral Investig; 2016 Jan; 20(1):43-56. PubMed ID: 25914047
[TBL] [Abstract][Full Text] [Related]
35. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
36. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
37. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions.
Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW
World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
39. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression.
Huang B; Jin G; Qu C; Ma H; Ding C; Zhang Y; Liu W; Li W
Med Sci Monit; 2019 Dec; 25():9939-9948. PubMed ID: 31874951
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
